PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
26-Mar-2020 Independent site management organisation Panthera prepares for COVID-19 Panthera Biopartners
26-Mar-2020 Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19 Grifols
26-Mar-2020 AMI’S POLYMER SUPPLY CHAIN CONFERENCE 2020 POSTPONED AMI
26-Mar-2020 ISCT stands against organisations marketing unproven COVID-19 CGTs The International Society for Cell & Gene Therapy (ISCT)
25-Mar-2020 TRANSPARENT PEER REVIEW COMES TO ROYAL SOCIETY OF CHEMISTRY Royal Society of Chemistry
25-Mar-2020 1 week to go to SMi’s 22nd Annual Superbugs & Superdrugs Conference  SMi Group
25-Mar-2020 Food Enzymes market is growing worldwide with the key market players such as Specialty Enzymes and Biotechnologies, Biosun, DSM, DuPont, Novozymes, AB Enzymes, Nutriteck, and many more Ricerca Alfa
24-Mar-2020 Speaker interview with Krystin Meidell from Biogen ahead of Pre-filled Syringes East Coast 2020 SMi Group
24-Mar-2020 Q&A with Team Consulting Ltd released for Injectable Drug Delivery 2020 SMi Group
24-Mar-2020 Cataract Devices market is flourishing around the globe though the key market players such as Abbott, Bausch & Lomb, Novartis, STAAR Surgical Company, Carl Zeiss AG, and Topcon Corporation among others Ricerca Alfa
24-Mar-2020 Global Cardiac Mapping Market| Focusing on Top Market Players including EP Solutions Sa, Abbott Laboratories, Koninklijke Philips N.V., Medtronic Plc, Microport Scientific Corporation, and Boston Scientific Corporation among others Ricerca Alfa
23-Mar-2020 Exclusive Allergan speaker interview released for Pre-Filled Syringes West Coast conference 2020 SMi Group
23-Mar-2020 Synairgen to start trial of SNG001 in COVID-19 imminently Synairgen plc
23-Mar-2020 Helsinn announces European approval of the IV formulation of AKYNZEO® (fosnetupitant / palonosetron) Helsinn Group
23-Mar-2020 Syncona Limited Business Update Syncona Limited
23-Mar-2020 All patients in the European MOB-015 Phase 3 study have completed their last visit Moberg Pharma AB
23-Mar-2020 Bone Therapeutics receives Clinical Trial Application (CTA) approval for next clinical studies of its two lead candidates BONE THERAPEUTICS
23-Mar-2020 Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy Vaccitech
23-Mar-2020 Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy Vaccitech Limited
23-Mar-2020 Immutep’s partner, EOC Pharma, reports completion of recruitment of phase I study of Efti Immutep